Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Clinical trial NCT03719105 · RECRUITING

Trial details

NCT number: NCT03719105
Sponsor: New York Medical College
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

NK-Cell Lymphoma NK-Cell Leukemia Peripheral T Cell Lymphoma

Start date: 2019-03-01
Primary completion: 2027-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.